Abstract
This presentation was given at the Movement Disorder Society International Congress of Parkinson’s Disease and Movement Disorders.
| Original language | American English |
|---|---|
| State | Published - Jun 15 2004 |
| Event | Movement Disorder Society International Congress of Parkinson’s Disease and Movement Disorders (MDS) - Rome, Italy Duration: Jun 15 2004 → … |
Conference
| Conference | Movement Disorder Society International Congress of Parkinson’s Disease and Movement Disorders (MDS) |
|---|---|
| Period | 06/15/04 → … |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Disciplines
- Public Health
- Epidemiology
Keywords
- Constipation
- Double-blind
- Parkinson's disease
- Randomized trial
- Tegaserod
- Treatment
- Zelnorm
Fingerprint
Dive into the research topics of 'A Double-Blind, Randomized Trial of Tegaserod (Zelnorm) in the Treatment of Constipation in Parkinson’s Disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver